Skip to main content
Clinical Trials/NCT00213733
NCT00213733
Completed
Not Applicable

Research of Molecular Markers for Diagnosis and/or Prognosis in Lymph Node Metastasis of Resected Non-small Cell Lung Cancer

University Hospital, Strasbourg, France5 sites in 1 country150 target enrollmentJune 2004
ConditionsLung Cancer

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Lung Cancer
Sponsor
University Hospital, Strasbourg, France
Enrollment
150
Locations
5
Status
Completed
Last Updated
14 years ago

Overview

Brief Summary

This is a prospective study of surgically resected samples and lymph nodes of lung cancer patients. For histopathologically positive lymph nodes from a complete resection, the investigators would like to analyse tumor tissue by allelotyping and comparing these results with those observed in the primary lung tumor to establish a cartography of molecular alteration in resected lung cancer. For non histopathologically positive lymph nodes, the investigators would like to research the presence (or not) of micrometastasis by allele-specific PCR (polymerase chain reaction).

Detailed Description

Genetic: It is a prospective study during two years with three years for follow-up. No control group is recruited.

Registry
clinicaltrials.gov
Start Date
June 2004
End Date
August 2011
Last Updated
14 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
University Hospital, Strasbourg, France

Eligibility Criteria

Inclusion Criteria

  • Patients with resectable non-small cell lung cancer (stage I to IIIA), with a complete resection of the tumor and paired lymph nodes.
  • Informed consent is required.

Exclusion Criteria

  • Another cancer
  • Chemotherapy before surgical treatment

Outcomes

Primary Outcomes

Not specified

Study Sites (5)

Loading locations...

Similar Trials